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Abstract It was recently reported in the murine model of
metastatic breast cancer (4T1) that tumor progression and de-
velopment of metastasis is associated with systemic endothe-
lial dysfunction characterized by impaired nitric oxide (NO)
production. Using Raman 3D confocal imaging with the anal-
ysis of the individual layers of the vascular wall combined
with AFM endothelial surface imaging, we demonstrated that
metastasis-induced systemic endothelial dysfunction resulted
in distinct chemical changes in the endothelium of the aorta.
These changes, manifested as a significant increase in the
protein content (18 %) and a slight decrease in the lipid con-
tent (4 %), were limited to the endothelium and did not occur
in the deeper layers of the vascular wall. The altered lipid to
protein ratio in the endothelium, althoughmore pronounced in
the fixed vascular wall, was also observed in the freshly iso-
lated unfixed vascular wall samples in the aqueous environ-
ment (12 and 7 % change of protein and lipid content, respec-
tively). Our results support the finding that the metastasis
induces systemic endothelial dysfunction that may contribute
to cancer progression.
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Introduction
Breast cancer is an insidious disease that is often not diag-
nosed at the initial, but rather at the late stage, when metasta-
ses in lymph nodes and distant organs are already formed. The
most common metastatic foci of breast cancer were detected
in the lungs, brain, pleura, liver, and bones. As it was shown in
the very recent work inNature [1], the process of formation of
metastatic sites is determined by tumor exosome integrins.
The tumor-derived exosomes (e.g., lung–tropic exosome with
special integrins) are directed toward specific organs and pre-
pare the pre-metastatic niche after reaching the place of desti-
nation (e.g., in the lungs). It means that direction of formation
of metastasis sites can be predicted based on integrins’ expres-
sion profiles of circulating plasma exosomes [1]. In order to
formmetastatic sites, migrating cancer cells have to overcome
the blood–tissue barrier in the circulatory system, i.e., the en-
dothelium. As long as the endothelial layer is healthy and
continuous, it plays a crucial role in vascular repair and tumor
invasiveness inhibition, while dysfunctional endotheliummay
act in the opposite way [2].
Raman spectroscopy is a label-free method providing
chemically specific information about the studied sample
[3]. Alterations occurring in tissues upon development of dis-
eases cause changes in the concentration and structure of the
biomolecules that is reflected in tissue Raman spectra. A
Raman-based approach enables not only characterization of
differences in the tissues of healthy and pathologic specimens,
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but also discrimination between the Raman spectra of normal
and abnormal tissues [4] that establishes a base of medical
diagnostics. Up to now [4–8], Raman studies on cancer con-
centrated on characterization of differences between cancer-
ous or precancerous and control tissues.
The spectral features of cancerous murine and human tis-
sues are remarkably similar. In the human breast tissues, the
changes in the relative content of fatty acids, triglycerides,
proteins, carotenoids and water were recognized as a hallmark
of cancer [7]. The main components of noncancerous tissues
were lipids with unsaturated fatty acids, while the Raman
spectra of cancerous tissues were dominated by bands origi-
nating from proteins [5]. In the murine model of the breast
cancer (BALB/c mice inoculated with 4T1 murine mammary
tumor cell line), changes in the chemical composition in breast
tissues [6, 8] and lymph nodes [8] were previously reported.
The distinction between normal mammary tissues from mam-
mary tumors was based on the decrease of lipid bands (1747
and 1302 cm−1) with the simultaneous increase of signals
associated with proteins (1265, 1002, and 850 cm−1) [8].
Moreover, Raman spectroscopy enabled detection of tissues
distinctly different from normal or tumor ones, i.e., tissues
with early biochemical changes prior to definite morphologic
tumor development [6].
To the best of our knowledge, the chemical changes occur-
ring in the vascular wall along the progression of primary
cancer and metastasis were not studied so far with the help
of Raman spectroscopy. In this work, we aimed to analyze
spectroscopic features of the vessel wall and particularly the
endothelium, the barrier for migrating cancer cells that was
recently proven to undergo significant alterations upon cancer
metastasis [2, 9]. Raman imaging was previously demonstrat-
ed to be an effective method of studying endothelium status in
the murine models of various diseases associated with endo-
thelial dysfunction including diabetes [10], hypertension [11],
and atherosclerosis [12]. In the present study, Raman confocal
imaging was used to investigate the influence of the metastatic
breast cancer on the endothelial layer of the murine aorta. We
characterized the considerable chemical changes occurring in
the aortic endothelium upon cancer-associated endothelial
dysfunction. 3D Raman imaging enabled to demonstrate that
biochemical tissue alterations were limited to the endothelial
layer, rather than the whole vessel wall and, therefore, could
be treated as a hallmark of endothelial dysfunction related to
cancer-induced systemic inflammation.
Materials and methods
Murine model of metastatic breast cancer
Seven- to eight-week-old BALB/c female mice (obtained
from Charles River Laboratories) were orthotopically
inoculated into the right mammary fat pad with 1×104 viable
4T1 tumor cells (obtained from American Type Culture
Collection) cultured according to previously described proto-
col [9]. Healthy BALB/c mice were used as a control group.
Analysis was conducted 6 weeks after cancer cell transplanta-
tion. Animals (n=5 for both control mice and mice with the
cancer metastasis) were anesthetized by an intraperitoneal in-
jection (i.p.) of a mixture consisting of ketamine and xylazine
(100mg ketamine/10 mg xylazine/kg body weight). The chest
was opened and the thoracic aorta was quickly removed and
transferred into Krebs–Henseleit buffer.
All experimental procedures involving animals were con-
ducted according to the Guidelines for Animal Care and
Treatment of the European Communities and the Guide for
the Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85-23, re-
vised 1996). All procedures were approved by the Local
Ethical Committee on Animal Experiments.
Preparation of fixed and unfixed aorta
For fixed tissue preparation, the resected and split-open arter-
ies were tightly glued to the Cell-Tak®-coated calcium fluo-
ride surface in air. Subsequently, the tissue was preserved by a
10-min soak in 4 % buffered formalin and twice flushed with
distilled water. The samples were measured after drying in air.
For unfixed sample preparation, the fragments of the aorta
were attached on Cell-Tak®-coated Petri dish and kept in min-
imal essential medium (MEM) with the addition of 1 %MEM
vitamins, 1 % antibiotics (penicillin 10,000 U/mL and strep-
tomycin 10,000 μg/mL), 1 % non-essential amino acids
(NEAA), and 20 % fetal bovine serum. Aorta preparations
were incubated at 37 °C and 5 % CO2 for at least 12 h.
Shortly before measurements, the samples were flushed twice
with isotonic phosphate buffer (PBS) at 37 °C and stored in it
during data acquisition. The temperature during measure-
ments was about 23 °C.
Instrumentation
Raman imaging was done with a Confocal Raman Imaging
system WITec alpha 300 with the application of a ×100 air
objective (Olympus, MPlan FL N, NA=0.9) and ×60 water
immersion objective (Nikon Fluor, NA=1) for fixed and
unfixed tissues, respectively. The laser excitation wavelength
of 532 nm, laser power of ca. 10 and 20mW, and the integration
time of 0.2 and 0.3 s/spectrum were used in all cases for fixed
and unfixed tissues, respectively. For both preparation methods,
images of the edge length of 15×15 μm2 (75×75 pixels2) were
recorded. The spectral resolution was 3 cm−1.
Subsequently after Raman measurements, AFM imaging
(Confocal Raman Imaging system WITec alpha 300) in the
pulsed force mode (PFM) with the force modulation probes
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(k=2.8 N/m, WITec) was performed for fixed tissues. The
resolution of images was 200×200 pixels2 for the area of
20×20 μm2.
WITec Project Plus 2.10 software was employed for data
preprocessing including cosmic ray removal. All spectra were
baseline corrected using a polynomial or autopolynomial
function of degree 2 for fixed and unfixed samples of the
vessel wall, respectively. The OPUS 7.2 program was used
for the vector normalization of the spectra (in the 3200–
450 cm−1 and 1500–200 cm−1 regions, for fixed and unfixed
samples, respectively), and calculations of the integral inten-
sity of the following bands: 2940 cm−1 (in the regions: 3030–
2825 cm−1 and 3012–2820 cm−1 for fixed and unfixed tissues,
respectively) and 1007 cm−1 (in the regions: 1023–993 cm−1
and 1016–997 cm−1 for fixed and unfixed tissues, respective-
ly). For statistical analysis, t test was evaluated using commer-
cial software (Origin Pro 9.1, OriginLab). Results are present-
ed as means±SEM. A difference between means was consid-
ered significant if p<0.05.
Results and discussion
Raman 3D-AFM imaging of murine aorta
The en face aorta was prepared with the endothelium facing
upwards, and thanks to the 3D confocal imaging, a separation
of Raman information from different layers was possible.
Each time, the measurements were started from the layer
where the Raman signal was the most intense, and this plane
was designated as Z=0.0 μm. Subsequently, precisely the
same area of the vascular wall was re-examined after moving
the objective by 0.5 μm up to such a plane where Raman
signal was unmeasurably low. In this way, the recorded set
of Raman spectra could be assigned to the lower and upper
parts of the aorta, corresponding to the media layers of the
vascular wall and the endothelium, respectively. This ap-
proach offered a unique possibility for the differential analysis
of the chemical changes in the endothelium and vascular part
of the vessel wall. Nevertheless, it should be added that the
information from Raman images may have not originated
strictly from one layer of the vessel wall due to variations in
endothelial layer thickness and natural roughness of the aorta.
The representative results of two complete measurements
of the vascular wall from the control specimen (left panel) and
the animal with the cancer metastasis (right panel) are present-
ed in Fig. 1.
Overall, the six and five 3D Raman and AFM measure-
ments were performed for control and metastatic mice, respec-
tively. During the experiment, the flat areas on the aorta sur-
face were selected preferentially (Fig. 1 A and A′) to obtain a
set of Raman spectra at different depths of the vessel wall with
the signal of the endotheliumwell separated from the signal of
the media layers (Fig. 1 B and B′). To confirm that the surface
was truly flat (there was no optical illusion on the visual im-
age), the AFM imaging was performed and the obtained to-
pographic images were compared to the Raman images (Fig. 1
C and C′). Additionally in this case, two times better spatial
resolution and incomparably better vertical resolution of AFM
compared to Raman imaging revealed the important and valu-
able surface details. The Raman spectra recorded during the
measurement of each layer was averaged to obtain one aver-
age Raman spectrum (Fig. 1 E and E′). The lipid to protein
ratio was calculated for every average spectrum individually
(Fig. 1 D and D′). The overall lipid content was calculated as
the ratio of the integral intensity of the band for lipids and
proteins (centered at 2940 cm−1 and assigned to the C–H
stretching vibrations [13]) to the protein marker band (at
1007 cm−1, assigned to the ring breathing mode of phenylal-
anine [14]).
For the control aorta, the apparent difference in the lipid to
protein ratio for the endothelium (upper layer, Z=1) relative to
the deeper layers is observed. It is evident that the vascular
endothelium of the control mice has the higher content of
lipids and/or the lower content of the proteins than the deeper
layers of the aorta. This effect was not observed in the vascular
wall of metastatic animals, where the lipid to protein ratio is
comparable for all measured layers. It demonstrates that me-
tastasis causes the endothelium alterations related to the
change of lipids and/or protein content.
In order to validate that observed differences between the
endothelium of control specimens and animals with metastasis
are also measurable in physiological conditions, a similar
methodology based on 3D Raman imaging was applied to
the unfixed aorta (Electronic Supplementary Material
(ESM), Fig. S1).
Metastasis influence on lipid and protein content
in the endothelium
The composition of the split-open murine aorta taken from
BALB/c mice at the advance stage of metastasis was com-
pared with that of the aorta taken from age-matched control
BALB/c mice. Six weeks after cancer cell transplantation, the
number of metastasis in the lung was 45.60±10.26, while in
control BALB/c mice the metastatic sites were not present.
Metastasis at this stage of disease was associated with robust
inflammation and the impairment of nitric oxide (NO)-depen-
dent vasodilation in the aorta [9]. Calculating the integral in-
tensities of marker bands in Raman spectra, it was found that
the most prominent differences in the vascular wall of control
and metastatic animals were related to the overall lipid and
protein content (marker bands at ca. 2940 and 1007 cm−1,
respectively).
In accordance with the methodology discussed above, ob-
tained Raman images were divided into two groups: upper
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(referring to the endothelium) and lower ones (referring to the
media layers). The complete analysis was performed individ-
ually for each group in order to verify in which parts of the
vascular wall alterations due to the pathology took place. The
results showing changes in the entire volume of the vascular
wall (all) and selectively in the endothelium (upper) andmedia
layers (lower) for fixed tissues are presented in Fig 2. The
results demonstrated similar trends for both fixed (Fig. 2)
and unfixed (ESM Fig. S2) samples of the vessel wall.
The simultaneous slight decrease of the overall lipid con-
tent and the significant increase in the protein level were ob-
served in the vascular wall (Fig. 2 A and A′). Both changes
were definitely limited to the endothelium layer (Fig. 2 B and
B′), while the lipid and protein content was practically un-
changed in the media layers for the studied group of mice
(Fig. 2 C and C′). It is clear that a specific response from the
endotheliumwas so significant (Fig. 2 B and B′) that it strong-
ly affected the results averaged over the whole measured con-
tent (Fig. 2 A and A′). Nevertheless, this 3D Raman imaging
approach clearly demonstrated that the disturbances in the
lipid and, particularly, protein level can be treated as a specific
endothelium response and a biomarker of endothelial dysfunc-
tion upon cancer metastasis.
In the measured volume of the vessel wall, the lipid content
insignificantly decreased for the metastatic mice relatively to
the control (Fig. 2(A)). Nevertheless, for the endothelium, this
effect was more pronounced i.e., the 4 % decrease in the lipid
content was observed for specimens with metastasis
(Fig. 2(B)). A considerably more striking effect of the metas-
tasis was the overproduction of proteins. The intensity of the
band at 1007 cm−1 increased up to 18% in the endothelium of
metastatic mice in comparison with the control (Fig. 2(B′)).
Also for the unfixed aorta, endothelium was the layer
primarily involved in the response to the cancer metastasis
(ESM Fig. S2). It is clear that the lipid level decreased
(7 %) and the protein content significantly increased
(approx. 12 %, p= 0.034) upon pathology development,
compared to the control. Although the trend was similar
if the whole volume of the sample was considered, no
statistically significant differences between the vascular
wall of the BALB/c mice at the advance stage of metastasis
and control were observed.
Fig. 1 Results of representative measurements of the vessel wall of a
control specimen (left panel) and a specimenwith metastasis (right panel)
(fixed samples). The areas of Raman and AFM measurements are
denoted with white and green rectangles, respectively, in the visual
images (A, A′). Three Raman distribution images at different depths of
the vascular wall were obtained by integration of the band in the range of
2800–3100 cm−1 (B, B′) and compared with the AFM topography (C,C′).
The lipid to protein ratio (D, D′), defined as the intensity ratio of the band
at 2940 cm−1 to the band at 1007 cm−1, was calculated based on the
average spectra (E, E′) of presented Raman images (B, B′)
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Spectral characteristics of metastasis-induced changes
in endothelium
Differences in the average spectral profiles of the control and
metastasis-altered endothelium both in fresh and fixed sam-
ples are presented in Fig. 3.
The most prominent differences in the Raman spectra of
control and metastasis-changed endothelium were noticeable
in the high wavenumber range (2800–3100 cm−1), where the
observed broad band at ca. 2940 cm−1 is a superposition of
features due to the stretching vibrations of various lipid and
protein CH2 and CH3 groups. The bands at ca. 2968 and
2940 cm−1 originate from the CH3 asymmetric and symmetric
stretching vibrations, respectively, for both proteins and lipids
[13]. The characteristic signal for lipids is a shoulder at
2881 cm−1 [13, 15]. The decrease of the intensity of the band
in the 2800–3100 cm−1 region (both for fixed and unfixed
samples) represents the overall decrease in the lipid to protein
ratio in the endothelium, as spectra were previously normal-
ized to the phenylalanine band. The band at 3053 cm−1 corre-
sponds to the C–H stretching vibrations observed in aromatic
amino acids (phenylalanine, tryptophan) [16]. In the analyzed
spectra, there is no contributions from the =CH stretching
modes, typically exhibited as the band at ca. 3005 cm−1 and
distinctive for unsaturated lipids [13]. Although the substan-
tial biochemical information on proteins is usually connected
to the band located at 1660 cm−1, i.e., the amide I [14], it is
obvious that this band is also related to lipids and assigned to
the C=C stretching vibrations of unsaturated triacylglycerols,
Fig. 2 Lipid and protein content
in the fixed vascular wall of
control andmetastatic mice: in the
entire volume of the measured
vascular wall (A, A′), in the
endothelium (B, B′) and in the
media layer (C, C′) (whiskers
denote standard errors, asterisk
denotes p<0.05)
Fig. 3 Characteristics of Raman average spectra of endothelium in the
fixed and unfixed vascular wall. The comparison of the average spectra of
the endothelium: control fixed (blue), metastasis-altered fixed (red),
control unfixed (green), and metastasis-altered unfixed (violet) mice.
Spectra were normalized to the phenylalanine band at 1007 cm−1
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cholesterols, and membrane lipids [13]. Nevertheless, the lack
of the band at 3005 cm−1 indicates a marginal contribution of
unsaturated lipids into the amide I band. For the unfixed aorta,
the analysis of the amide I band is evenmore complicated, due
to water contribution. Both effects, broadening of the amide I
band and the presence of the very intense featureless band at
ca. 3300 cm−1 for spectra of the unfixed aorta, resulted from
water environment. The band at around 1452 cm−1 is attribut-
ed to the CH2 waggingmodes and contains overlapped signals
from lipids [13] and proteins [14].
Conclusions
Alterations in the vascular wall of the aorta in the murine model
of metastatic breast cancer (4T1) were studied with the help of
3D Raman-AFM imaging of the endothelium. We introduced a
novel methodology to study a vascular wall and identified that
the chemical changes in the aorta taken frommice at the stage of
advance metastasis related mostly to the increase of the protein
content accompanied by the decrease of the lipid content. Our
approach was based on the 3D confocal imaging of the vessel
wall and enabled the analysis of the endothelial and vascular
muscle layers of the aorta individually. Application of this ap-
proach resulted in the conclusion that observed chemical changes
were limited to the endothelium.
Importantly, in the same experimental model of the murine
metastatic breast cancer (4T1), we reported that tumor pro-
gression and development of metastasis resulted in the impair-
ment of NO-dependent function in the aorta that was most
likely due to the robust cancer-associated inflammation [9].
Accordingly, in the present work, using the same model, for
the first time we characterized the biochemical correlates of
the endothelial dysfunction associated with cancer metastasis.
Here, we identified that the increase of the protein content
accompanied by the slight decrease of the lipid content is the
prominent feature of cancer metastasis-induced peripheral en-
dothelial dysfunction. The fall in lipids is difficult to explain,
although cellular endothelial injury of any kind is associated
with a fall of lipid content. The increased content of proteins,
however, may be related to the activation of pro-inflammatory
and pro-thrombotic endothelial phenotype. Indeed, in the ad-
vanced stage of cancer progression (6th week after cancer cell
inoculation), the impairment of NO-dependent response in the
aorta was associated with the upregulation of vascular COX-
2-derived PGI2 and increased expression of von Willebrand
factor, vWF [9]. Furthermore, various pro-inflammatory path-
ways can be activated in the dysfunctional state of the endo-
thelium when NO production is impaired including VCAM-1,
ICAM-1, other adhesion molecules, MCP-1, and other
chemokines and many other pro-inflammatory molecules.
Interestingly, the phenotype of “cancer-associated” dysfunc-
tional endothelial cells (DECs) was characterized in vitro [2]
showing that the expression of many pro-inflammatory NF-ĸB
target genes was significantly increased while the expression of
quiescence-promoting, anti-inflammatory genes was decreased.
DECs seemed to bemuchmore active, e.g., secretedmuch larger
amounts of proteins [2]. Taking all these data together, we sug-
gest that changes in the protein content of endothelial cells, ob-
served in Raman spectra, result from dysfunctional activation of
the endothelium related to cancer and ongoing inflammation.
Coincidently, the biochemical changes in the endothelium, i.e.,
the increase of the protein and the decrease of the lipid content
upon cancer metastasis, are exactly the same as the alterations in
the tissue upon its transformation into breast tumor itself [17].
What is the pathophysiologicalmeaning of this fact remains to be
elucidated.
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